Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$22,341,975
+$904,162 QoQ
Shares Held
117,825
+8.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#225
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTECH INVESTMENT MANAGEMENT LLC holds $283,727,682 across 11 Drug Manufacturers - General names. AZN ranks #3 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
87,915 | $105,447,897 | |
| 2 | JNJ |
Johnson & Johnson
|
292,522 | $74,291,811 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
117,825 | $22,341,975 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
305,070 | $17,578,132 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
135,233 | $17,085,336 | |
| 6 | MRK |
Merck & Co., Inc.
|
126,723 | $16,283,905 | |
| 7 | ABBV |
AbbVie Inc.
|
46,148 | $11,612,682 | |
| 8 | AMGN |
Amgen Inc
|
31,159 | $11,283,297 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,341,975 | 117,825 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $21,437,813 | 108,700 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||